Crossmark

Pretreatment systemic inflammation response index is predictive of pathological complete response in patients with breast cancer receiving neoadjuvant chemotherapy

Crossref DOI link: https://doi.org/10.1186/s12885-021-08458-4

Published Online: 2021-06-14

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Dong, Jie

Sun, Qingqing

Pan, Yueyin

Lu, Nannan

Han, Xinghua

Zhou, Qiong
License Information

Text and Data Mining valid from 2021-06-14

Version of Record valid from 2021-06-14
More Information

Article History

Received: 18 January 2021

Accepted: 7 June 2021

First Online: 14 June 2021

Declarations

:

: The ethics committee of The First Affiliated Hospital of USTC approved the study. And informed consent was exempted by the ethics committee of The First Affiliated Hospital of USTC due to the retrospective nature of the study. All methods were conducted in accordance with relevant guidelines and regulations.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below